Companies

Vaxart Inc

NASDAQ: VXRT
$0.50
▼ $0.00 (−0.33%) today
Markets closed · 9:19pm ET
Today · % change

About Vaxart

Vaxart Inc is a trailblazing biotech firm focused on revolutionizing vaccines by making them available in oral tablet form, rather than traditional injections. This innovative approach is being applied to a range of infectious diseases, including norovirus, seasonal influenza, respiratory syncytial virus, coronavirus, and human papillomavirus (HPV), with several vaccines currently undergoing clinical trials. Based in South San Francisco, California, Vaxart's mission is to enhance vaccine accessibility and acceptance worldwide.

VXRT Coverage

1:45pm ET
Health and Healthcare

Why Vaxart’s New Flu Vaccine Is So Great

Vaxart shares more than doubled on Thursday after the company announced positive results from the midstage trial of its influenza oral tablet vaccine.

Chris Lange